Table 1 Clinicopathological features of our 188 patients with advanced urothelial bladder cancer treated with adjuvant chemotherapy
Variable | N (%) or variable unit |
|---|---|
Median age (years) at cystectomy (range) | 62 (35–79) |
Gender | |
Female | 31 (17) |
Male | 157 (83) |
pT stage, N (%) | |
T0 | 7 (4) |
Tis | 1 (1) |
Ta | 1 (1) |
T1 | 4 (2) |
T2 | 25 (13) |
T3 | 94 (50) |
T4 | 56 (29) |
pN stage, N (%) | |
Nx | 18 (9) |
N0 | 28 (15) |
N1 | 45 (24) |
N2 | 96 (51) |
N3 | 1 (1) |
Treatment | |
Adjuvant chemotherapy regimen | |
G | 1 (1) |
GC | 131 (69) |
GCb | 45 (24) |
MVAC | 9 (5) |
Other | 2 (1) |
Histological variant of primary tumors (N = 178)* | |
Pure conventional urothelial carcinoma | 68 (38) |
Urothelial carcinoma with divergent differentiation | |
Squamous differentiation | 44 (25) |
Glandular differentiation | 4 (2) |
Micropapillary carcinoma | 50 (28) |
Pure micropapillary carcinoma | 20 |
Mixte micropapillary carcinoma | 30 |
Plasmacytoid/single-cell carcinoma | 13 (7) |
Sarcomatoid carcinoma | 23 (13) |
Giant cell | 1 (1) |
Microcystic | 1 (1) |
